GENEXTRA

nov 12
8

Intercept Pharmaceuticals Intercept Pharmaceuticals to Present Phase 2a Portal Hypertension Data...
oct 12
11

Intercept Pharmaceuticals Intercept Pharmaceuticals Announces Pricing of Initial Public Offering
aug 12
9

Intercept Pharmaceuticals Intercept Pharmaceuticals and Servier Announce Agreement
aug 11
9

Intercept Pharmaceuticals Intercept Pharmaceuticals and Servier Announce Agreement
may 11
2

Intercept Pharmaceuticals Dainippon intercepts bile acids
mar 11
31

Intercept Pharmaceuticals Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid
jul 10
6

Atlante Ventures acquires interest in Tethis (Genextra Group)
jan 10
25

Genextra Genextra further invests $25 million series B financing in Intercept Pharmaceuticals
jan 10
25

Intercept Pharmaceuticals Raises $25 Million Series B Financing
dec 09
14

Genextra S.p.A. raises over € 36 million in equity financing

more news...

Please Downloads our:

- Corporate fact sheet 2012 (194KB)

reserved area